Paolo Lusso

Q: What Schools Are Affiliated With Paolo Lusso

Paolo Lusso is affiliated with the following schools: University of Milan, Stanford University, University of Turin, University of Cagliari, University of Bologna

Paolo Lusso's AcademicInfluence.com Rankings

Paolo Lusso

Physics

#7381

World Rank

#9409

Historical Rank

Cosmology

#245

World Rank

#256

Historical Rank

Astrophysics

#618

World Rank

#666

Historical Rank

physics Degrees

Download Badge

Physics

Paolo Lusso's Degrees

PhD Physics University of Milan
Masters Physics University of Milan
Bachelors Physics University of Milan

Why Is Paolo Lusso Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paolo Lusso's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8+ T Cells (1995) (2825)
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. (1995) (911)
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression (1997) (692)
The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection (1996) (533)
CD46 Is a Cellular Receptor for Human Herpesvirus 6 (1999) (523)
Productive dual infection of human CD4+ T lymphocytes by HIV-1 and HHV-6 (1989) (324)
In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6) (1988) (322)
Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. (1995) (309)
Chromosomally integrated human herpesvirus 6: questions and answers (2011) (306)
Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 (1995) (281)
Induction of CD4 and susceptibility to HIV-1 infection in human CD8+ T lymphocytes by human herpesvirus 6 (1991) (271)
Classification of HHV-6A and HHV-6B as distinct viruses (2014) (266)
Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization (1994) (260)
HIV and the chemokine system: 10 years later (2006) (230)
Infection of natural killer cells by human herpesvirus 6 (1993) (212)
Human herpes virus‐6 increases HIV‐1 expression in co‐infected T cells via nuclear factors binding to the HIV‐1 enhancer. (1989) (211)
CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. (1994) (198)
Viral DNA carried by human immunodeficiency virus type 1 virions (1992) (198)
Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses (2000) (190)
Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes (2003) (177)
C–C Chemokines Released by Lipopolysaccharide (LPS)-stimulated Human Macrophages Suppress HIV-1 Infection in Both Macrophages and T Cells (1997) (176)
Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7. (2005) (169)
Human B-lymphotropic virus (human herpesvirus-6). (1988) (162)
Activation of CD8+ T lymphocytes through the T cell receptor turns on CD4 gene expression: implications for HIV pathogenesis. (1998) (151)
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load (2008) (151)
HBLV (orHHV-6) in human cell lines (1987) (149)
Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. (1990) (148)
Real-Time Quantitative PCR for Human Herpesvirus 6 DNA (2000) (142)
CXCR4 is a functional coreceptor for infection of human macrophages by CXCR4-dependent primary HIV-1 isolates. (1998) (138)
Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele (1997) (138)
Productive infection of CD4+ and CD8+ mature human T cell populations and clones by human herpesvirus 6. Transcriptional down-regulation of CD3. (1991) (134)
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6) (1988) (130)
Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. (1993) (127)
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report (2009) (124)
Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. (1999) (114)
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 (2001) (114)
Selective suppression of IL-12 production by human herpesvirus 6. (2003) (112)
Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4. (2007) (112)
Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells. (1994) (112)
Human herpesvirus 6 in AIDS. (1995) (111)
Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection (1995) (107)
Glycosylation, hypogammaglobulinemia, and resistance to viral infections. (2014) (107)
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis (2013) (104)
Clinical significance of HIV-1 coreceptor usage (2011) (103)
Rapid Diagnosis of Mycobacterial Infections and Quantitation of Mycobacterium tuberculosis Load by Two Real-Time Calibrated PCR Assays (2003) (102)
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity. (1988) (101)
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages (1993) (99)
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. (2006) (99)
HBLV (or HHV-6) in human cell lines. (1987) (97)
Pathogenic Effects of Human Herpesvirus 6 in Human Lymphoid Tissue Ex Vivo (2003) (97)
Cryptic Nature of a Conserved, CD4-Inducible V3 Loop Neutralization Epitope in the Native Envelope Glycoprotein Oligomer of CCR5-Restricted, but Not CXCR4-Using, Primary Human Immunodeficiency Virus Type 1 Strains (2005) (96)
Recognition of RANTES by extracellular parts of the CCR5 receptor. (2007) (95)
Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression (1994) (93)
Role of β-Chemokines in Suppressing HIV Replication (1996) (93)
Recognition of virus-infected cells by natural killer cell clones is controlled by polymorphic target cell elements (1993) (91)
Role of the extracellular domain of human herpesvirus 7 glycoprotein B in virus binding to cell surface heparan sulfate proteoglycans (1997) (89)
Disseminated human herpesvirus 6 infection In AIDS (1993) (88)
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor (2012) (82)
Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (82)
Quantitative PCR for human herpesviruses 6 and 7 (1995) (82)
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (2012) (79)
Human herpesvirus 6A accelerates AIDS progression in macaques (2007) (77)
Interaction of Glycoprotein H of Human Herpesvirus 6 with the Cellular Receptor CD46* (2003) (76)
Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1. (1990) (74)
Human herpesvirus 6 in AIDS (1994) (73)
Viral Replication-Independent Blockade of Dendritic Cell Maturation and Interleukin-12 Production by Human Herpesvirus 6 (2005) (70)
Different stages of B cell differentiation in non-T acute lymphoblastic leukemia. (1984) (69)
Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function* (2002) (69)
Pregnancy outcome in patients with pityriasis rosea. (2008) (67)
Longitudinal analysis of serum chemokine levels in the course of HIV-1 infection. (1999) (66)
Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1. (1988) (65)
DIVERSE TROPISM OF HUMAN B-LYMPHOTROPIC VIRUS (HUMAN HERPESVIRUS 6) (1987) (63)
Engineering of Lactobacillus jensenii To Secrete RANTES and a CCR5 Antagonist Analogue as Live HIV-1 Blockers (2010) (63)
Chemokines and viruses: the dearest enemies. (2000) (61)
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer (2011) (60)
Chemokines as natural HIV antagonists. (2002) (60)
CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses (1990) (60)
Expression of CD4 on human peripheral blood neutrophils. (2003) (58)
Viral Interactions in Human Lymphoid Tissue: Human Herpesvirus 7 Suppresses the Replication of CCR5-Tropic Human Immunodeficiency Virus Type 1 via CD4 Modulation (2006) (58)
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals (2007) (57)
Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. (1993) (56)
Human Herpesvirus 6 (HHV-6) Causes Severe Thymocyte Depletion in SCID-hu Thy/Liv Mice (1999) (55)
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein. (2008) (54)
Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases (2013) (54)
Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES (2001) (53)
Calibrated Real-Time PCR Assay for Quantitation of Human Herpesvirus 8 DNA in Biological Fluids (2002) (52)
Discrepancy between phenotypic and functional features of natural killer T‐lymphocytes in B‐cell chronic lymphocytic leukaemia (1984) (52)
Detection of human herpesvirus 6 and human papillomavirus 16 in cervical carcinoma. (1994) (50)
Enhancement of the HIV‐1 inhibitory activity of RANTES by modification of the N‐terminal region: dissociation from CCR5 activation (2000) (50)
In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo (1990) (49)
Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. (1999) (48)
CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV–1 strains in a T–cell line (1995) (47)
Rational design of novel HIV-1 entry inhibitors by RANTES engineering. (2008) (46)
Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization. (1996) (45)
Immunomodulation and immunosuppression by human herpesvirus 6A and 6B. (2013) (45)
Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing (2017) (44)
Immature T lymphocytes in human cord blood identified by monoclonal antibodies: a model for the study of the differentiation pathway of T cells in humans. (1984) (43)
Persistent infection of rhesus macaques with a molecular clone of human immunodeficiency virus type 2: evidence of minimal genetic drift and low pathogenetic effects (1990) (42)
Biological and molecular characteristics of human herpesvirus 7: in vitro growth optimization and development of a syncytia inhibition test. (1994) (41)
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. (2009) (40)
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4pos T cells and macrophages (2013) (40)
A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques (2021) (40)
CD4 IS NOT THE MEMBRANE RECEPTOR FOR HHV-6 (1989) (40)
Inhibition of HIV-1 Infection by Human α-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae (2012) (39)
Increased proportion of suppressor/cytotoxic (OKT8+) cells in patients with Hodgkin's disease in long‐lasting remission (1983) (39)
Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes. (1996) (38)
Human herpesvirus 6 (HHV-6). (1996) (37)
Inhibition of CXCR4-Tropic HIV-1 Infection by Lipopolysaccharide: Evidence of Different Mechanisms in Macrophages and T Lymphocytes1 (2002) (37)
Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer. (2018) (35)
HIV and chemokines: implications for therapy and vaccine. (2002) (35)
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population (1985) (33)
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 (2013) (33)
Effect of reciprocal complementation of two defective human immunodeficiency virus type 1 (HIV-1) molecular clones on HIV-1 cell tropism and virulence (1992) (32)
Non-cytotoxic inhibition of HIV-1 infection by unstimulated CD8+ T lymphocytes from HIV-exposed-uninfected individuals (2002) (32)
Monoclonal antibodies raised against covalently crosslinked complexes of human immunodeficiency virus type 1 gp120 and CD4 receptor identify a novel complex-dependent epitope on gp 120. (1995) (32)
Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques (2012) (31)
Reduced natural killer T‐cells in B‐cell chronic lymphocytic leukaemia identified by three monoclonal antibodies: Leu‐11, A10, AB8.28 (1986) (31)
Development of Reverse Transcriptase PCR Assays for Detection of Active Human Herpesvirus 6 Infection (2001) (31)
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples. (2013) (30)
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2–V3 interaction and modulates neutralization sensitivity (2014) (30)
Differential Responses of Plasmacytoid Dendritic Cells to Influenza Virus and Distinct Viral Pathogens (2014) (30)
Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection. (1997) (27)
Human herpesvirus 8 (HHV-8/KSHV) and hematologic malignancies. (2003) (27)
A relapsing inflammatory syndrome and active human herpesvirus 8 infection. (2005) (27)
In vitro susceptibility of Macaca nemestrina to human herpesvirus 6: a potential animal model of coinfection with primate immunodeficiency viruses. (1994) (26)
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A (2009) (26)
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay (2012) (24)
Effect of alpha-interferon on the immune system of patients with hairy cell leukemia. (1987) (24)
Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation. (2015) (23)
Nonrandom TRGγ variable gene rearrangement in normal human T cells and T cell leukemias (1988) (23)
Improvement of antibody functionality by structure-guided paratope engraftment (2019) (23)
Human herpesvirus type 7 in Hodgkin's disease (1998) (23)
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT (2008) (22)
Molecular engineering of RANTES peptide mimetics with potent anti‐HIV‐1 activity (2011) (22)
3' c-myc rearrangement in a human leukemic T-cell line. (1986) (22)
HHV-6 and CMV pneumonitis in immunocompromised patients (1994) (21)
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. (1985) (20)
Differentiated human neural stem cells: a new ex vivo model to study HHV-6 infection of the central nervous system. (2006) (20)
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma (2018) (20)
Human herpesvirus 6. (1995) (20)
HHV-8 DNA replication correlates with the clinical status in AIDS-related Kaposi's sarcoma. (2016) (20)
Coinfection of SCID-hu Thy/Liv Mice with Human Herpesvirus 6 and Human Immunodeficiency Virus Type 1 (2000) (19)
Pathogenesis of AIDS. (1992) (19)
Molecular and immunological evidence of B‐cell commitment in “null” acute lymphoblastic leukaemia (1986) (18)
Recent developments in animal models for human herpesvirus 6A and 6B. (2014) (17)
Productive infection of HUVEC by HHV-8 is associated with changes compatible with angiogenic transformations. (2009) (17)
Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2). (1987) (16)
HIV vaccine delayed boosting increases Env variable region 2-specific antibody effector functions. (2020) (15)
Enhancement of TAT‐induced transactivation of the HIV‐1 LTR by two genomic fragments of HHV‐6 (1996) (15)
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. (1985) (15)
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants. (2009) (15)
Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. (2002) (14)
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2. (2011) (14)
Qualitative and quantitative polymerase chain reaction detection of the residual myeloma cell contamination after positive selection of CD34+ cells with small‐ and large‐scale Miltenyi cell sorting system (2002) (14)
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity. (2006) (14)
Diverse tropism of HBLV (human herpesvirus 6) (1987) (12)
Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1 (2015) (12)
CHEMOKINES AND HIV INFECTION (1997) (12)
Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides. (2012) (12)
HHV-6B infection, T-cell reconstitution, and graft-vs-host disease after hematopoietic stem cell transplantation (2018) (12)
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages. (2009) (12)
Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation (2018) (12)
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. (1987) (12)
Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry (2016) (12)
Phenotypic and functional characterization of the circulating NK compartment in hairy cell leukaemia. (1986) (12)
Morphological and ultrastructural changes induced in corneal epithelial cells by HIV-1 and HHV-6 in vitro. (1996) (11)
Chemokine receptors as new molecular targets for antiviral therapy. (2004) (11)
Utilization of human hematopoietic cell lines for the propagation and characterization of HBLV (human herpesvirus 6). (1989) (11)
Protein-based HIV-1 microbicides. (2014) (10)
Immunological dysregulation of lymph nodes in AIDS patients. (1991) (10)
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability (2012) (10)
Viral DNA Carried byHumanImmunodeficiency Virus Type1Virions (1992) (9)
Reaction Patterns of the Lymph Node (1991) (9)
Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees (2020) (9)
Response: Role of β-Chemokines in Suppressing HIV Replication (1996) (9)
Release of interleukin-2-like material by B-chronic lymphocytic leukemia cells. An autocrine or paracrine model of production and utilization? (1988) (9)
Multistage carcinogenesis utilizing human genital cells and human papillomaviruses. (1994) (9)
Analysis of serum and plasma beta chemokines in primary HIV infection (PHI). (2000) (8)
Extremely potent monoclonal antibodies neutralize Omicron and other SARS-CoV-2 variants (2022) (8)
Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. (1982) (8)
C-C chemokine RANTES and HIV long terminal repeat-driven gene expression. (1997) (8)
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection (2009) (7)
Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations. (2017) (7)
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays (2013) (7)
Functional Anatomy of the Trimer Apex Reveals Key Hydrophobic Constraints That Maintain the HIV-1 Envelope Spike in a Closed State (2021) (7)
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses. (2012) (7)
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (7)
Picking the lock with a hairpin. Did HIV-1 learn the art from chemokines? (2003) (6)
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 (2011) (6)
Chemokines and HIV: The First Close Encounter (2015) (6)
Normal T-Lymphocyte Function in Patients with Hodgkin's Disease in Long-Lasting Remission (1986) (5)
Relevance of monoclonal antibodies in the diagnosis of unusual T-cell acute lymphoblastic leukaemia. (2009) (5)
Virus-encoded chemokines, chemokine receptors and chemokine-binding proteins: new paradigms for future therapy (2007) (5)
CD8+ T lymphocyte-derived chemokines and other HIV-suppressive factors: mini-review. (1998) (5)
Proliferative T‐Cell Response to HIV Envelope Glycoprotein in Immunized and Infected Primates and Human Beings (1989) (5)
Integrin α4β7 in HIV‐1 infection: A critical review (2020) (5)
Corrigendum: Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer (2017) (4)
Interaction of HBLV (HHV-6) With EBV and HIV (1989) (4)
A human leukemic T cell line (PF-382) inhibits the growth of myeloid and erythroid progenitor cells. (1987) (4)
A matrix of structure-based designs yields improved VRC01-class antibodies for HIV-1 therapy and prevention (2021) (4)
A chemokine trap for HIV co-receptors (1997) (4)
Unsung Hero Robert C. Gallo (2009) (4)
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys (2022) (4)
Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1. (1989) (4)
New EMBO Member's Review HIV and the chemokine system: 10 years later (2006) (3)
Anti-PF4 antibodies associated with disease severity in COVID-19 (2022) (3)
Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (3)
Rational Engraftment of Quaternary-Interactive Acidic Loops for Anti-HIV-1 Antibody Improvement (2021) (3)
Nonrandom TRG gamma variable gene rearrangement in normal human T cells and T cell leukemias. (1988) (3)
P-D3 Structural determinants for the selective Anti-HIV-1 activity of the all-beta alternative conformer of XCL1 (2016) (3)
Chapter 3 Target cells for infection (1992) (3)
P-D4 Tyrosine-sulfated peptides from the gp120 V2 domain block HIV-1 entry through CCR5 Mimicry (2016) (3)
Effects of 12-o-tetradecanoyl-phorbol-13-acetate (TPA) on the colony growth of human T lymphocytes. (1984) (3)
Accelerated progression to AIDS in macaques coinfected with simian immunodeficiency virus and human herpesvirus 6A (2006) (3)
Response: Role of beta-Chemokines in Suppressing HIV Replication. (1996) (3)
Normal helper T-cell function in hairy-cell leukaemia. (2009) (3)
HHV-6 and HIV-1 Infection (2006) (2)
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells (2022) (2)
Biological Features of HHV-6 (2006) (2)
INTERACTIONS BETWEEN HHV-6 AND HIV: HHV-6 AS A POTENTIAL COFACTOR IN AIDS (1994) (2)
Multi-step purification strategy for RANTES wild-type and mutated analogues expressed in a baculovirus system. (2000) (2)
Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies (2021) (2)
Chapter 10 Interactions between HHV-6 and other viruses (1992) (2)
Epidemiology of infection with HIV-1 in Sardinia: A multicentre prospective study (2006) (1)
Possibility that transmissible viruses might be involved in the etiology of human cancer. (2003) (1)
107 Interleukin-7 as an Immune Reconstitution Agent in HIV-1 Infection: Ex Vivo and In Vivo Protective Effects on CD4+ T Cells (2012) (1)
High prevalence of human herpes virus 6 DNA in Hodgkin's disease: a study by in situ hybridization and polymerase chain reaction (1995) (1)
Design of RANTES-derived Peptides With Enhanced HIV-inhibitory Activity and Derivation of Resistant HIV-1 Strains (2005) (1)
Immunological and Molecular Classification of Human Leukemias (1986) (1)
The P-selectin ligand PSGL-1 (CD162) is efficiently incorporated by primary HIV-1 isolates and can facilitate trans-infection (2021) (1)
P-C21 Molecular Mimicry of a Helical Region in Domain 1 of CD4 Facilitates Interdomain Stabilization of HIV-1 gp120 (2017) (1)
73: Human herpesvirus 6 and multiple sclerosis: detection by quantitative real-time PCR and role of complement-mediated damage secondary to CD46 inactivation (2006) (1)
Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group (2008) (1)
UvA-DARE (Digital Academic Repository) Clinical significance of HIV-1 coreceptor usage (1)
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants (2022) (1)
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4 pos (2013) (1)
Prolonged asymptomatic HIV-1 infection. (2000) (1)
Considerations on human Herpesvirus 6 reactivation after cord blood transplantation (2018) (1)
Human herpesvirus-6 may be a cofactor in AIDS. (1991) (1)
Chemokines and Chemokine Receptors in HIV Infection (2003) (1)
I-101 Quaternary contact improves the potency of broadly neutralizing antibodies to the CD4-binding site of HIV-1 (2019) (0)
Characterization of HIV-1 entry inhibitors with broad activity against R5 and X4 viral strains (2015) (0)
Chromosomally int 6 : questions and an Reviews in Medical Virology (2011) (0)
P-D6 Structure-Function Relationships in the Second Variable Domain (V2) of HIV-1 gp120 (2014) (0)
Macrophages by CXCR4-Dependent Primary Coreceptor for Infection of Human Cutting Edge: CXCR4 Is a Functional (2013) (0)
MIP-1β but not IFN-γ are associated with nonprogressive HIV-1 infection (2010) (0)
RANTES mutants and therapeutic uses thereof (1998) (0)
Fighting HIV: a little help from Toxoplasma ? (2003) (0)
7q-and loss of a polymorphism for the met oncogene in a patient with myelofibrosis (1987) (0)
Improvement of antibody functionality by structure-guided paratope engraftment (2019) (0)
of nucleic acid quantification method. (1998) (0)
P-D5 Two conserved tyrosines in the HIV-1 envelope V2 loop play a critical role in gp120/gp41 association (2016) (0)
in Non-T Acute Lymphoblastic Leukemia (1984) (0)
Conformational Changes in HIV-1 Env Trimer Induced by a Single CD4 as Revealed by Cryo-EM (2017) (0)
The quest for an HIV-1 vaccine: will mRNA deliver us from evil? (2023) (0)
P-D14 Increasing the Level of Tyrosine Sulfation Alters the Antigenic Profile of the BG505 SOSIP.664 Trimer (2014) (0)
A Structure-Based Matrix Approach Yields Improved VRC01-Class Antibodies for HIV-1 Therapy and Prevention (2020) (0)
Classification of HHV-6A and HHV-6B as distinct viruses (2013) (0)
Suppression of Primate Immunodeficiency Lentiretroviruses by CD8+ T-Cell-Derived Soluble Factors (2000) (0)
Translocation of the c-myc oncogene 3′ to the immunoglobin heavy chain enhancer in the tumor DNA from a Burkitt lymphoma (1986) (0)
HIV Research in the SCID Mouse: Biosafety Considerations (2005) (0)
HHV-6 and CMV pneumonitis in immunocompromised patients. (1994) (0)
A method for quantitative detection of nucleic acids (1999) (0)
Chapter 17 – Human Herpesvirus 6 (1999) (0)
IL4 HHV-6 AND THE IMMUNE SYSTEM (2007) (0)
Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques (2022) (0)
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. (1991) (0)
ResearchNef-specific CD 45 RA + CD 8 + T cells secreting MIP-1 β but not IFN-γ are associated with nonprogressive HIV-1 infection (2015) (0)
In Reply: Pseudotypes in HIV-Infected Mice. (1990) (0)
Mutants rantes et leurs applications therapeutiques (1998) (0)
Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters (2022) (0)
Distribution of HHV-8 in blood cells of Kaposi's sarcoma patients: Evidence for HHV-8 infection of CD34+ cells (1998) (0)
B-111 Sulfotyrosine-mediated V2-V3 interaction stabilizes the HIV-1 envelope trimer facilitating immune evasion (2016) (0)
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4posT cells and macrophages (2013) (0)
Cervical Carcinoma (2020) (0)
18: Quantitation of viral DNA in biological fluids: from the bench to the bedside (2006) (0)
released IL 2 is absorbed by the neoplastic B cell population from patients with B-chronic lymphocytic leukemia: evidence that normally Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes (2013) (0)
D-106 Tyrosine Sulfation in the Second Variable Domain (V2) of gp120 Regulates HIV-1 Sensitivity to Neutralization (2014) (0)
Lymphocytes Mechanisms in Macrophages and T by Lipopolysaccharide : Evidence of Different Inhibition of CXCR 4-Tropic HIV-1 Infection (2002) (0)
P-D4 Inhibition of HIV-1 by the C-chemokine XCL1/Lymphotactin is dependent on high affinity binding to glycosaminoglycans (GAG) (2014) (0)
Chronic T‐cell leukaemias. A variant of T‐prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases (1987) (0)
Cc chemokine that prevent infection with viruses reto (1996) (0)
[OK T-positivity in stimulated T-lymphocytes]. (1982) (0)
Intracellular immunization against HIV-1 by poly-TAR RNA elements (1991) (0)
Milestones: Dr. Robert C. Gallo and the Discovery of HIV-1 (2023) (0)
B cells from chronic lymphocytic leukemia (CLL) patients are strong inducers of proliferation and major histocompatibility complex (MHC)-unrestricted [natural killer (NK)-like] cytotoxicity in normal T-lymphocytes (1989) (0)
F-103 Structure–Function Elucidation of the Native HIV-1 Envelope Trimer As a Basis for Rational Vaccine Design (2017) (0)
RANTES mutants and their therapeutic applications (1998) (0)
Persistent Infection ofRhesusMacaques witha Molecular Cloneof HumanImmunodeficiency VirusType2:Evidence ofMinimal Genetic Drift andLowPathogenetic Effects (1990) (0)
Cytopathic Infection Of Natural Killer (nk) Cells By Hiv-6: Induction Of Cd4 And Susceptibility To Hiv-1 Infection (1993) (0)
139 Epitope Masking Mechanism Within the HIV-1 Env Trimer Analyzed by Functional Subunit Complementation (2012) (0)
[Effect of human plasma on the in vitro formation of T-lymphocyte colonies]. (1982) (0)
P-C6 tyrosine-sulfated peptides from the V2 loop of gp120 Are potent HIV-1 inhibitors (2017) (0)
P-selectin glycoprotein ligand-1 (PSGL-1/CD162) is incorporated into clinical HIV-1 isolates and can mediate virus capture and subsequent transfer to permissive cells (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paolo Lusso?

Paolo Lusso is affiliated with the following schools:

Paolo Lusso's Academic­Influence.com Rankings

Paolo Lusso's Degrees

Why Is Paolo Lusso Influential?

Paolo Lusso's Published Works

Published Works

What Schools Are Affiliated With Paolo Lusso?

Paolo Lusso's AcademicInfluence.com Rankings